HighTide Therapeutics, Inc. (HKG:2511)
Hong Kong
· Delayed Price · Currency is HKD
2.750
-0.130 (-4.51%)
Jun 23, 2025, 3:56 PM HKT
HighTide Therapeutics Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 81.23 | 136.67 | 43.43 | 48.06 |
| Research & Development | 363.53 | 311.57 | 182.65 | 84.01 |
| Operating Expenses | 444.75 | 448.24 | 226.08 | 132.08 |
| Operating Income | -444.75 | -448.24 | -226.08 | -132.08 |
| Interest Expense | -1.53 | -0.4 | -0.43 | -4.53 |
| Interest & Investment Income | 29.18 | 24.28 | 12.38 | 3.33 |
| Currency Exchange Gain (Loss) | 3.12 | -0.89 | -7.52 | 0.6 |
| Other Non Operating Income (Expenses) | 38.79 | 8.17 | 8.2 | 5.28 |
| EBT Excluding Unusual Items | -375.2 | -417.07 | -213.45 | -127.39 |
| Gain (Loss) on Sale of Investments | -6.11 | - | - | - |
| Gain (Loss) on Sale of Assets | -0.21 | - | - | -0 |
| Other Unusual Items | - | -522.16 | 23.24 | -93.66 |
| Pretax Income | -381.52 | -939.23 | -190.21 | -221.05 |
| Income Tax Expense | 0.27 | 0.08 | 0.03 | 0.1 |
| Net Income | -381.79 | -939.31 | -190.24 | -221.15 |
| Net Income to Common | -381.79 | -939.31 | -190.24 | -221.15 |
| Shares Outstanding (Basic) | 452 | 260 | 255 | 42 |
| Shares Outstanding (Diluted) | 452 | 260 | 255 | 42 |
| Shares Change (YoY) | 74.08% | 1.91% | 506.17% | - |
| EPS (Basic) | -0.84 | -3.62 | -0.75 | -5.26 |
| EPS (Diluted) | -0.84 | -3.62 | -0.75 | -5.26 |
| Free Cash Flow | -302.75 | -357.42 | -172.56 | -92.29 |
| Free Cash Flow Per Share | -0.67 | -1.38 | -0.68 | -2.19 |
| EBITDA | -443.75 | -447.7 | -225.68 | -131.8 |
| D&A For EBITDA | 1.01 | 0.54 | 0.41 | 0.28 |
| EBIT | -444.75 | -448.24 | -226.08 | -132.08 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.